Viatris Inc.VTRS
NasdaqGS•Healthcare•Drug Manufacturers - Specialty & Generic
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $14.56B, growing 1.6% year-over-year. TTM net income stood at $-296.50M (92.2% growth). Quarterly EBITDA was $596.40M and operating income was $-79.70M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze VTRS growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters